Morgan Stanley Says SpaceX Is Worth $300 Per Share. The Stock Trades Near $140. Here's Who I Think Is Right.

SpaceX shares have fallen nearly 35% since its June 12 IPO (trading back around the $150 area), but Morgan Stanley highlights upside tied to the AI business and a $300 price target. The firm argues the Cursor/Grok AI story is undervalued and expects Cursor to lift its revenue run rate from ~$4B (June) to ~$8B by year-end, then ~$17B (2027) and ~$33B (2028). The article cautions that SpaceX’s heavy losses likely persist for years, citing projected negative free cash flow of about -$105B in 2029 before a turnaround.

Analysis

This is less a fundamental re-rating than a duration trade on when the market is willing to underwrite negative cash flow for a platform story. In the near term, the key mechanism is multiple compression: if investors don’t see a clean path from usage to cash generation, every incremental dollar of AI rhetoric is discounted at a higher rate, not a lower one. That makes the stock vulnerable to any secondary offering, lock-up expiration, or even a weak quarter from adjacent AI names that resets risk appetite.

The real winners are the financing and distribution layer, not the story asset itself. MS should capture the most direct benefits from ongoing capital markets activity, cross-sell, and any future monetization event; GOOGL gets a more indirect option value if enterprise AI workflows are expanding rather than cannibalizing spend. By contrast, software incumbents like ADBE face a second-order risk that code-generation tools compress pricing power and slow net expansion rates, even if gross usage rises.

The contrarian miss is that “AI optionality” is not equivalent to earnings power. Until investors can see operating leverage, the market will likely punish long-duration names with high implied future losses, especially if rates back up or mega-cap AI spend slows. Over 1-3 months, the setup is fragile; over 6-18 months, the thesis only works if a credible monetization bridge appears before dilution or capex overwhelms sentiment.

Key Decisions for Investors

• Overweight MS vs GS over the next 1-3 months: MS is better levered to capital-raising and secondary activity around speculative AI assets; target 10-15% relative outperformance if issuance stays active, but cut if IPO pipelines stall.
• Buy ADBE downside hedges or run a small short vs NVDA: the risk/reward favors the infrastructure provider over the workflow incumbent if AI code generation continues to commoditize software seats; revisit if ADBE re-accelerates net retention or raises FY guidance.
• Avoid chasing SPCX on the upside until there is visible cash conversion; if available, use call spreads only after a confirmed post-lock-up dip rather than paying peak implied volatility.
• Watch GOOGL as a cleaner expression of enterprise AI adoption; a long only works if usage expands without major margin leakage, so require evidence of AI monetization in cloud/ads before adding aggressively.